Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
135.08B | 152.41B | 125.93B | 110.05B | 95.31B | 81.59B | Gross Profit |
69.14B | 84.66B | 73.82B | 63.01B | 52.74B | 40.95B | EBIT |
40.40B | 57.08B | 50.81B | 42.91B | 34.60B | 22.83B | EBITDA |
44.72B | 63.56B | 54.25B | 46.30B | 37.39B | 25.62B | Net Income Common Stockholders |
31.80B | 43.37B | 36.74B | 32.55B | 24.92B | 15.95B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
29.86B | 125.19B | 102.12B | 107.26B | 71.24B | 65.66B | Total Assets |
86.62B | 243.48B | 217.37B | 187.37B | 163.71B | 143.47B | Total Debt |
18.60B | 12.16B | 11.75B | 6.10B | 6.83B | 7.93B | Net Debt |
-11.26B | -113.03B | -90.36B | -101.17B | -64.41B | -57.73B | Total Liabilities |
32.66B | 48.40B | 56.24B | 40.89B | 42.92B | 43.73B | Stockholders Equity |
53.96B | 195.08B | 161.13B | 146.47B | 120.80B | 99.73B |
Cash Flow | Free Cash Flow | ||||
30.29B | 31.79B | 14.37B | 42.88B | 11.50B | 19.94B | Operating Cash Flow |
34.55B | 36.92B | 21.79B | 46.95B | 14.63B | 22.28B | Investing Cash Flow |
-4.64B | -5.96B | -7.68B | -7.43B | -4.23B | -8.44B | Financing Cash Flow |
-18.62B | -15.97B | -22.48B | -9.98B | -6.96B | -6.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$12.44B | 39.28 | 22.64% | 0.89% | ― | ― | ||
61 Neutral | $14.60B | 5.95 | -4.32% | 3.69% | 2.76% | -30.49% | |
¥2.68T | 36.69 | 16.43% | 0.82% | ― | ― | ||
$14.40B | 17.60 | 12.67% | 0.84% | ― | ― | ||
$3.84B | 14.61 | 11.92% | 1.71% | ― | ― | ||
$7.44B | 46.56 | 7.32% | 1.37% | ― | ― | ||
72 Outperform | ¥766.83B | 19.25 | 2.62% | -1.70% | 11.29% |